GBM	Glioblastomas
WHO	The World Health Organization
TMZ	Temozolomide
rGBM	Recurrent glioblastoma
mOS	Median overall survival
OV	Oncolytic virus
HSV-1	Herpes simplex virus-1
Ad	Adenovirus
NDV	Newcastle disease virus
RV	Reovirus
oHSV	Oncolytic herpes simplex virus
TK	Thymidine kinase protein
dNMP	Deoxyribonucleotides
PKR	Protein kinase R
RR	Ribonucleotide reductase
pfu	Plaque forming units
GSC	Glioblastoma stem cells
pHGG	Pediatric high-grade glioma
DIPG	Diffuse intrinsic pontine glioma
scFv	Single chain fragment variable
TAP	The antigen presenting
MHLW	Ministry of Health, Labour and Welfare
CRAds	Cancer-Selective Replicating Adenoviruses
5-FU	5-fluorouracil
CAR	Coxsackie adenovirus receptor
mE1A	Mutant E1A
CPT-11	Camptothecin analogue irinotecan
RGD	Arginine-glycine aspartic acid
pHGG	Pediatric high-grade gliomas
DIPGs	Diffuse intrinsic pontine gliomas
vp	Viral particles
RT	Radiotherapy
4-1BBL	4-1BB ligand
DNX-2440	Delta-24-RGDOX
OX40L	OX40 ligand
pRb	The retinoblastoma tumor suppressor protein
PVSRIPO	Recombinant nonpathogenic polio-rhinovirus chimera
CD	Cytosine deaminase
Toca FC	Prodrug 5-fluorocytosine
SOC	Standard of care
ZIKV	Zika virus
GSCs	Glioblastoma multiforme stem cells
3’UTR	3’ untranslated region
BBB	Blood-brain barrier
TME	Tumor microenvironment
CED	Convection-enhanced delivery